FDA warns about side effects of Zyprexa in children

02/1/2010 | Los Angeles Times (tiered subscription model)

The FDA warned medical professionals that adolescents taking the antipsychotic drug olanzapine, or Zyprexa, may be more likely to gain weight and have metabolic problems compared with adults. The drug, while widely prescribed, is not approved for children under age 13, and the FDA said providers should consider long-term potential risks when prescribing it for adolescents.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN